Inventor · disambiguated record
David Brown
Also filed as: BROWN DAVID · BROWN DAVID DONALDSON
29 granted patents·50 pending applications·641 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
79 records- 0198US9506061B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Nov 29, 2016·165 cites·7 claims
- 0296US8173611B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2005·Granted May 8, 2012·27 cites·27 claims
- 0396US7960359B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2007·Granted Jun 14, 2011·37 cites·17 claims
- 0496US7919245B2Methods and compositions involving microRNAASURAGEN INC·Filed 2007·Granted Apr 5, 2011·67 cites·13 claims
- 0596US7888010B2Methods and compositions involving microRNAASURAGEN INC·Filed 2005·Granted Feb 15, 2011·78 cites·14 claims
- 0695US8568971B2Methods and compositions involving microRNABROWN DAVID·Filed 2010·Granted Oct 29, 2013·36 cites·28 claims
- 0795US8058250B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2007·Granted Nov 15, 2011·20 cites·31 claims
- 0894US8563708B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2007·Granted Oct 22, 2013·15 cites·9 claims
- 0994US8465914B2Method and compositions involving microRNABROWN DAVID·Filed 2012·Granted Jun 18, 2013·34 cites·16 claims
- 1093US8258111B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisSHEN JIKUI·Filed 2009·Granted Sep 4, 2012·48 cites·16 claims
- 1192US8946177B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2011·Granted Feb 3, 2015·10 cites·16 claims
- 1290US8071562B2MiR-124 regulated genes and pathways as targets for therapeutic interventionBADER ANDREAS G·Filed 2008·Granted Dec 6, 2011·48 cites·11 claims
- 1389US8524680B2High potency siRNAS for reducing the expression of target genesBROWN DAVID·Filed 2009·Granted Sep 3, 2013·12 cites·18 claims
- 1489US8003320B2Methods and compositions involving MicroRNAASURAGEN INC·Filed 2007·Granted Aug 23, 2011·8 cites·9 claims
- 1585US9447414B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Sep 20, 2016·2 cites·3 claims
- 1685US9365852B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisMIRNA THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·2 cites·6 claims
- 1785US9051571B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 9, 2015·3 cites·28 claims
- 1885US8765709B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2013·Granted Jul 1, 2014·3 cites·22 claims
- 1983US9382537B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jul 5, 2016·2 cites·10 claims
- 2083US9068219B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 30, 2015·2 cites·33 claims
- 2183US8900627B2Compositions for the in vivo delivery of RNAi agentsFORD LANCE·Filed 2009·Granted Dec 2, 2014·6 cites·29 claims
- 2282US8597892B2MiRNA biomarkers of prostate diseaseSHELTON JEFFREY·Filed 2010·Granted Dec 3, 2013·7 cites·9 claims
- 2381US11470845B2Multi-target antimicrobial compositions comprising chitosanCHINOVA BIOWORKS INC·Filed 2018·Granted Oct 18, 2022·4 cites·15 claims
- 2475US8735074B2MiRNA biomarkers of lung diseaseMAMBO ELIZABETH·Filed 2010·Granted May 27, 2014·5 cites·37 claims
- 2575US2025387426A1Methods of treating migraine headache or tension headache with hyaluronic acidBROWN DAVID DONALDSON·Filed 2025·Application pending·0 cites
- 2673US11882832B2Multi-target antimicrobial compositions comprising chitosanCHINOVA BIOWORKS INC·Filed 2022·Granted Jan 30, 2024·0 cites·12 claims
- 2773US2025339461A1Methods of treating migraine headache or tension headache with hyaluronic acidBROWN DAVID DONALDSON·Filed 2025·Application pending·0 cites
- 2871US10047388B2Methods and compositions involving MicroRNABROWN DAVID·Filed 2013·Granted Aug 14, 2018·0 cites·16 claims
- 2968US2024370011A1Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccinesRNAIMMUNE INC·Filed 2024·Application pending·0 cites
- 3068US2024294580A1Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccinesRNAIMMUNE INC·Filed 2024·Application pending·0 cites
- 3167US12280105B2Compositions and methods of mRNA vaccines against novel coronavirus infectionRNAIMMUNE INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 3267US2017037404A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2016·Application pending·0 cites
- 3367US2013303591A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 3466US2024374697A1MULTIPLEXED TP53 AND PAN-RAS mRNA CANCER VACCINESSHEN DONG·Filed 2023·Application pending·0 cites
- 3566US2013143945A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 3665US2014179762A1METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 3764US9540645B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisMIRNA THERAPEUTICS INC·Filed 2016·Granted Jan 10, 2017·0 cites·6 claims
- 3864US2015361431A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 3964US2014295543A1Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interferenceAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 4063US2015342981A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 4163US2009263803A1Mirnas differentially expressed in lymph nodes from cancer patientsBEAUDENON SYLVIE·Filed 2009·Application pending·0 cites
- 4263US2015284720A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 4363US2013231266A1METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 4463US2015344883A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 4563US2015299705A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 4663US2011313025A1Methods and compositions involving mirna and mirna inhibitor moleculesBROWN DAVID·Filed 2011·Application pending·0 cites
- 4763US2015284719A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 4863US2015275213A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 4962US12280104B2Composition and methods for MRNA vaccines against novel omicron coronavirus infectionsRNAIMMUNE INC·Filed 2023·Granted Apr 22, 2025·0 cites·30 claims
- 5062US2011151558A1METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →